Sharekhan

Lasa Supergenerics Ltd

Tue 18/11/2025,15:46:59 NSE: LASA

₹ 10.11 -0.20 (-1.94%)
BUY NOW Buy Lasa Supergenerics Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Lasa Supergenerics Ltd

Tue 18/11/2025,16:1:0

Lasa Supergenerics Ltd

Tue 18/11/2025,15:46:59 | NSE : LASA

₹ 10.11-0.20 (-1.94%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 10.33

Previous Close

₹ 10.31

Volume

30728

Mkt Cap ( Rs. Cr)

₹50.65

High

₹ 10.50

Low

₹ 9.84

52 Week High

₹ 31.40

52 Week Low

₹ 8.16

Book Value Per Share

₹ 16.71

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Lasa Supergenerics Ltd

Your Vote -

Buy

26.92%

Hold

3.85%

Sell

69.23%

26.92%

26 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

13.59

9997

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

9997

Option Chain

Analyzes market sentiment, predicts Lasa Supergenerics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Lasa Supergenerics posts Q2 net loss of Rs 6.25 cr

    14 Nov 2025, 7:45PM The company reported standalone net loss during the quarter stood at Rs 6.25 crore as compared to net loss of Rs 3.23 crore in the previous year quart

  • Lasa Supergenerics - Updates

    14 Nov 2025, 7:00PM Lasa Supergenerics Limited has informed the Exchange regarding 'Related party transaction 30.09.2025'.

  • Lasa Supergenerics - Related Party Trasnaction As 30.09.2025

    14 Nov 2025, 6:58PM Related party transaction as on 30.09.2025

  • Lasa Supergenerics - Outcome of Board Meeting

    14 Nov 2025, 6:44PM Lasa Supergenerics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

  • Lasa Supergenerics - Integrated Filing- Financial

    14 Nov 2025, 6:21PM Integrated filing September 30, 2025

  • Lasa Supergenerics - Integrated Filing September 30 ,2025

    14 Nov 2025, 6:19PM Integrated filing September 30, 2025

  • Lasa Supergenerics - Updates

    14 Nov 2025, 5:34PM Lasa Supergenerics Limited has informed the Exchange regarding 'Results for the quarter ended September 30, 2025'.

  • Lasa Supergenerics - Results As On 30 Th Septemer 2025

    14 Nov 2025, 5:28PM Results as on 30.09.2025

  • Lasa Supergenerics - Outcome of Board Meeting

    14 Nov 2025, 5:10PM Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on November 14, 2025.

  • Lasa Supergenerics - Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended 30 September, 2025

    14 Nov 2025, 5:06PM Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Boar

  • Lasa Supergenerics - Reg. 34 (1) Annual Report.

    5 Sep 2025, 10:40PM Annual Report for the financial year ended March 31, 2025 along with Notice of the Tenth (10th ) Annual General Meeting and Cut-off Date for the purpo

  • Lasa Supergenerics - Update on board meeting

    10 Nov 2025, 1:44PM The Board Meeting to be held on 14/11/2025 has been revised to 14/11/2025 The Board Meeting to be held on 14/11/2025 has been revised to 14/11/2025

  • Lasa Supergenerics - Board Meeting Intimation for The Quarter And Half Year Ended September 30, 2025

    5 Nov 2025, 5:03PM Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider a

  • Lasa Supergenerics - Structural Digital Database

    20 Oct 2025, 12:46PM SDD Certificate for the quarter ended September 30, 2025

  • Lasa Supergenerics has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    17 Oct 2025, 3:20PM As of September 2025, 53.65% is owned by Indian Promoters and 46.35% by Public. <p align=justify> Top Promoter holding highest number of shares of Las

  • Lasa Supergenerics - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    14 Oct 2025, 3:20PM Lasa Supergenerics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Lasa Supergenerics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Oct 2025, 2:45PM Please find enclosed herewith certificate of 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended September, 30 2025 received from RTA Bigshare

  • Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2025, 7:47PM In terms of the subject referred the details regarding consolidated voting results of the business transacted at the 10th Annual General Meeting (AGM)

  • Lasa Supergenerics - Shareholders meeting

    1 Oct 2025, 7:44PM Lasa Supergenerics Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2025. Further, the co

  • Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2025, 7:47PM In terms of the subject referred the details regarding consolidated voting results of the business transacted at the 10th Annual General Meeting (AGM)

  • Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2025, 7:47PM In terms of the subject referred the details regarding consolidated voting results of the business transacted at the 10th Annual General Meeting (AGM)

  • Lasa Supergenerics - Shareholders meeting

    30 Sep 2025, 4:35PM Lasa Supergenerics Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2025

  • Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Outcome of AGM

    30 Sep 2025, 4:15PM Pursuant to Reg 30 SEBI (LODR), 2015 as amended we hereby submitting the summary of the proceedings of the 10 th AGM of the Company held on 30th Septe

  • Lasa Supergenerics - Trading Window

    29 Sep 2025, 4:29PM Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulation

  • Lasa Supergenerics - General Updates

    22 Sep 2025, 4:01PM Lasa Supergenerics Limited has informed the Exchange about General Updates

  • Lasa Supergenerics - Annoucement Under Reg 30 Updates - Revised Disclosure Resignation Of Company Secretary

    22 Sep 2025, 3:54PM With the reference to the earlier disclosure submitted dated 29th August , 2025. We hereby submitting the revised Disclosure

  • Lasa Supergenerics - Updates

    12 Sep 2025, 1:40PM Lasa Supergenerics Limited has informed the Exchange regarding 'Updates'.

  • Lasa Supergenerics - Shareholders meeting

    3 Sep 2025, 5:49PM Lasa Supergenerics Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange rega

  • Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    3 Sep 2025, 5:45PM We wish to informed you members of the Company has approved by way of postal ballot the resolution as set out in the Notice of Postal Ballot dated : 0

  • Lasa Supergenerics - Shareholders meeting

    3 Sep 2025, 5:39PM Lasa Supergenerics Limited has informed the Exchange regarding Proceedings of Postal Ballot

  • Lasa Supergenerics - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    3 Sep 2025, 5:31PM We wish to inform you that the members of the Company has approved by the way of postal ballot , the resolution under Companies Act 2013 and SEBI List

  • Lasa Supergenerics - Change in Company Secretary/Compliance Officer

    29 Aug 2025, 7:12PM Lasa Supergenerics Limited has informed the Exchange about Change in Company Secretary/Compliance Officer

  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    29 Aug 2025, 7:04PM With the reference to the Reg 30 of SEBI LODR resgulations, 2015 , we here inform you that Mrs Mitti Jain, Company Secretary and Compliance Officer of

  • Lasa Supergenerics to start trial runs from Nov 25

    23 Nov 2017 , 12:13PM Lasa Supergenerics announces that it will start its pilot production trial runs at its Unit IV from November 25, 2017
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Lasa Supergenerics Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 96.6762 118.2859 148.6341 158.9171 175.9458
Liabilities 96.6762 118.2859 148.6341 158.9171 175.9458
Equity 50.1012 50.1012 40.6727 40.6727 40.6727
Gross Profit 2.1658 -6.5935 15.6327 47.221 29.948
Net Profit -21.7306 -38.6207 -5.3672 22.7777 3.6284
Cash From Operating Activities 2.1387 -17.3004 10.4898 41.3103 13.6224
NPM(%) -20.82 -29.8 -3.91 11.25 2.16
Revenue 104.335 129.5678 137.1267 202.3795 167.2712
Expenses 102.1692 136.1613 121.494 155.1585 137.3232
ROE(%) -25.95 -46.13 -6.41 27.2 4.33

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
16 Sep 2022 0.25 2.5 0 62.35
15 Sep 2021 0.25 2.5 0 73.6

Peers

Other companies within the same industry or sector that are comparable to Lasa Supergenerics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 771.35 -2.86 15.40 92.48 337.37 1.17
Amines and Plasticizers Ltd 197.03 -0.50 29.99 56.40 372.61 0.25
Indogulf Cropsciences Ltd 96.05 -2.92 11.46 24.11 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 34.71 464.75 346.70 0.43

Company Info

Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.

Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.

Read More

Parent Organisation

Lasa Supergenerics Ltd.

Founded

11/11/2016

Managing Director

Dr.Omkar Pravin Herlekar

NSE Symbol

LASABE

FAQ

The current price of Lasa Supergenerics Ltd is ₹ 10.11.

The 52-week high for Lasa Supergenerics Ltd is ₹ 10.50 and the 52-week low is ₹ 9.84.

The market capitalization of Lasa Supergenerics Ltd is currently ₹ 50.65. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Lasa Supergenerics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Lasa Supergenerics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Lasa Supergenerics Ltd shares.

The CEO of Lasa Supergenerics Ltd is Dr.Omkar Pravin Herlekar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT